Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of Clinical Oncology

• Publication date

  1993-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.1993.11.10.1990PMID 8410124
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autologous bone marrow transplantation.

  1993cited by this paper
• Autologous bone marrow transplantation

  1993cited by this paper
• GIMEMA ALL 0288: a multicentric study on adult acute lymphoblastic leukemia. Preliminary results.

  1992cited by this paper
• Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). The EORTC Leukemia Cooperative Study Group.

  1992cited by this paper
• Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission.

  1991cited by this paper
• Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance.

  1991cited by this paper
• Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB Study.

  1991cited by this paper
• Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction.

  1991cited by this paper
• Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report.

  1991cited by this paper
• Comparison of chemotherapy and autologous and allogeneic transplantation as postinduction regimen in adult acute lymphoblastic leukemia: a preliminary multicentric study.

  1990cited by this paper
• Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission.

  1990cited by this paper
• Acute lymphoblastic leukemia: recent advances in biology and therapy.

  1989cited by this paper
• Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocol.

  1989cited by this paper
• Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults

  1988cited by this paper
• Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults.

  1988cited by this paper
• Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults.

  1988cited by this paper
• Allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia in first complete remission.

  1988cited by this paper
• A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969.

  1988cited by this paper
• Treatment of 218 adult acute lymphoblastic leukemias.

  1987cited by this paper
• Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease.

  1987cited by this paper
• Acute lymphoblastic leukemia in adults: recent progress, future directions.

  1987cited by this paper
• ALLOGENEIC BONE MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA DURING FIRST COMPLETE REMISSION

  1987cited by this paper
• Marrow transplantation for patients with acute lymphoblastic leukemia in first marrow remission.

  1987cited by this paper
• Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.

  1987cited by this paper
• Autologous bone marrow transplantation for acute leukaemia in remission

  1986cited by this paper
• Differentiation-linked leukemogenesis in lymphocytes.

  1986cited by this paper
• Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group B.

  1984cited by this paper
• Bone marrow transplantation for acute nonlymphoblastic leukaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.)

  1984cited by this paper
• Bone marrow transplantation for acute lymphoblastic leukaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.)

  1984cited by this paper
• Recent advances in the biology and treatment of acute lymphoblastic leukemia in adults.

  1984cited by this paper
• Results of induction therapy with vincristine and prednisone alone in adult acute lymphoblastic leukemia: Report of 43 patients and review of the literature

  1982cited by this paper
• Clinical studies with rubidazone.

  1979cited by this paper
• Marrow transplantation for patients with acute lymphoblastic leukemia in remission.

  1979cited by this paper
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

  1977cited by this paper
• Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group

  1976cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults.

  1968cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Autologous stem cell transplantation for adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. A study by the Acute Leukemia Working Party of the EBMT

  2025cites this paper
• Blinatumomab added to conditioning regimen of allogeneic hematopoietic stem cell transplantation for adult MRD-positive acute lymphoblastic leukemia: a single-center case series

  2025cites this paper
• Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation

  2023cites this paper
• Acute Lymphoblastic Leukemia Presenting Initially as Spinal Cord Compression: When Chemotherapy Alone Is Enough

  2020cites this paper
• Long-term outcomes and risk factor analysis of steroid-refractory graft versus host disease after hematopoietic stem cell transplantation

  2020cites this paper
• Consolidation: Autologous Stem Cell Transplantation in Acute Leukemia

  2020cites this paper
• EBV-associated post-transplant lymphoproliferative disease in patients who received anti-CD 20 after hematopoietic stem cell transplantation.

  2019cites this paper
• Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia

  2019cites this paper
• 6 Cellular Therapy of ALL

  2018cites this paper
• Managing CNS disease in adults with acute lymphoblastic leukemia

  2018cites this paper
• Hematopoietic stem cell transplant in adults with acute lymphoblastic leukemia: the present state

  2018cites this paper
• Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in older adults: Current treatment and novel therapies.

  2017cites this paper
• Brain Accumulation of Ponatinib and Its Active Metabolite, N-Desmethyl Ponatinib, Is Limited by P-Glycoprotein (P-GP/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2).

  2017cites this paper
• Recommendations for cerebrospinal fluid examination in acute leukemia.

  2017cites this paper
• Consolidations intensives dans la leucémie aiguë lymphoblastique du sujet âgé : une étude rétrospective

  2017cites this paper
• Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell Transplantation.

  2016cites this paper
• Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study

  2016cites this paper
• Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: Myeloablative, non-myeloablative, and beyond

  2015cites this paper
• High sensitivity of flow cytometry improves detection of occult leptomeningeal disease in acute lymphoblastic leukemia and lymphoblastic lymphoma

  2014cites this paper
• Superior survival of unmanipulated haploidentical hematopoietic stem cell transplantation compared with chemotherapy alone used as post-remission therapy in adults with standard-risk acute lymphoblastic leukemia in first complete remission.

  2014cites this paper
• Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-analysis.

  2013cites this paper
• (Ph+ ALL) outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia Early molecular response to posttransplantation imatinib determines

  2013cites this paper
• The superiority of allogeneic hematopoietic stem cell transplantation from unrelated donor over chemotherapy for adult patients with high-risk acute lymphoblastic leukemia in first remission

  2013cites this paper
• Diagnosis and Treatment of Adult Acute Lymphoblastic Leukemia

  2013cites this paper
• Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in adults

  2012cites this paper
• An auto-SCT-based total therapy resulted in encouraging outcomes in adolescents and young adults with acute lymphoblastic leukemia: report from a single center of China

  2012cites this paper
• Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.

  2012cites this paper
• Phase II Study of Intensive Post-remission Chemotherapy and Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma : Japan Clinical Oncology Group Study , JCOG 9402

  2012cites this paper
• The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence-based review.

  2012cites this paper
• Role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review.

  2012cites this paper
• Recent Developments in the Management of T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma

  2012cites this paper
• Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukaemia

  2012cites this paper
• Current therapeutic strategies in adult acute lymphoblastic leukemia.

  2011cites this paper
• Autologous stem cell transplantation vs chemotherapy in adult acute lymphocytic leukaemia

  2011cites this paper
• Induction Therapy in Adult Acute Lymphoblastic Leukemia

  2011cites this paper
• Interpreting data on transplant selection and outcome in adult acute lymphoblastic leukemia (ALL).

  2011cites this paper
• Autologous hematopoietic cell transplantation for high-risk ALL

  2011cites this paper
• Cellular Therapy of ALL

  2011cites this paper
• A Perspective on the Treatment of Acute Lymphoblastic Leukemia in Adults

  2011cites this paper
• Management of adult patients with acute lymphoblastic leukemia in first complete remission

  2010cites this paper
• Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review.

  2010cites this paper
• Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia (ALL)

  2010cites this paper
• Alternatives thérapeutiques à la L-asparaginase native dans le traitement de la leucémie aiguë lymphoblastique de l'adulte

  2010cites this paper
• 24B-Cell Acute Lymphoblastic Leukemia

  2010cites this paper
• Akute Iymphatische Leukämie bei Erwachsenen und Kindern

  2010cites this paper
• Problèmes spécifiques liés au traitement des leucémies aiguës chez la femme

  2010cites this paper
• Precursor B-Cell Acute Lymphoblastic Leukemia

  2010cites this paper
• ALL) + (Ph Philadelphia-positive acute lymphoblastic leukemia + outcome in MRD Early molecular response to posttransplantation imatinib determines

  2009cites this paper
• Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in adults.

  2009cites this paper
• Optimal management of adults with ALL

  2009cites this paper
• Central nervous system disease in hematologic malignancies: historical perspective and practical applications.

  2009cites this paper
• Allogeneic hematopoietic cell transplantation is not recommended for all adults with standard-risk acute lymphoblastic leukemia in first complete remission.

  2009cites this paper
• Isolated CNS lymphoid blast crisis in a patient with imatinib-resistant chronic myelogenous leukemia: case report and review of the literature.

  2009cites this paper
• Acute Lymphoblastic Leukemia in Adults

  2009cites this paper
• Role of allogeneic hematopoietic cell transplantation in adults with acute lymphoblastic leukemia

  2009cites this paper
• Evolving paradigms in the therapy of Philadelphia-chromosome-negative acute lymphoblastic leukemia in adults.

  2009cites this paper
• Prophylaxis and therapy of central nervous system involvement in adult acute lymphoblastic leukemia: recommendations of the Polish Adult Leukemia Group.

  2008cites this paper
• The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review.

  2008cites this paper
• The role of maintenance chemotherapy after autotransplantation for acute lymphoblastic leukemia in first remission: single-center experience of 100 patients

  2008cites this paper
• Central nervous system involvement in adult acute lymphoblastic leukemia

  2008cites this paper
• Relapsed Acute Lymphoblastic Leukemia

  2008cites this paper
• cute Lymphoblastic Leukemia ( Adult ) Including Lymphoblastic lymphoma

  2008cites this paper
• In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: fin

  2008cites this paper
• Acute Lymphocytic Leukemia in Adults

  2008cites this paper
• Allogeneic and Autologous Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia in the Adult

  2008cites this paper
• [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].

  2008cites this paper
• Conventional Therapy in Adult Acute Lymphoblastic Leukemia: Review of the LALA Program

  2008cites this paper
• Allogeneic hematopoietic cell transplantation for adults with ALL

  2008cites this paper
• Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA‐87 and LALA‐94 trials

  2007cites this paper
• Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.

  2007influential citation
• Place de l’autogreffe de cellules souches hématopoïétiques dans le traitement des hémopathies de l’adulte

  2007cites this paper
• Post-remission treatment for adult patients with acute lymphoblastic leukemia in first remission: is there a role for autologous stem cell transplantation?

  2007cites this paper
• Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial

  2007cites this paper
• Leucémies aiguës lymphoblastiques de l'adulte

  2007cites this paper
• How I treat acute lymphocytic leukemia in adults.

  2007cites this paper
• Does p16ink4a expression increase with the number of cell doublings in normal and malignant lymphocytes?

  2007cites this paper
• Initial and late prognostic factors to predict survival in adult acute lymphoblastic leukaemia

  2006cites this paper
• Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a metaanalysis.

  2006cites this paper
• Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study

  2006cites this paper
• Autogreffe de cellules souches hématopoïétiques en hématologie

  2006cites this paper
• Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993.

  2006cites this paper
• Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials

  2006cites this paper
• Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high‐risk acute lymphoblastic leukemia

  2006cites this paper
• Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia: A Guide to Therapy

  2006cites this paper
• In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: fin

  2006cites this paper
• The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review.

  2006cites this paper
• Autologous stem cell transplant in ALL: who should we be transplanting in first remission?

  2006cites this paper
• Reduced-intensity stem-cell transplantation for adult acute lymphoblastic leukemia: a retrospective study of 33 patients

  2005cites this paper
• N-desmethyl clozapine as purging agent of leukemic cells in vitro.

  2005cites this paper
• Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).

  2005cites this paper
• The role of ABC-transporters in childhood and adult acute lymphoblastic leukemia

  2005cites this paper
• Ph Philadelphia-positive acute lymphoblastic leukemia + outcome in MRD Early molecular response to posttransplantation imatinib determines

  2005cites this paper
• Conditioning regimens Reduced-intensity stem-cell transplantation for adult acute lymphoblastic leukemia : a retrospective study of 33 patients

  2005cites this paper
• Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial.

  2005cites this paper
• Conferences and Reviews Biology and Treatment of Adult Acute Lymphoblastic Leukemia

  2005cites this paper
• Developing a European network for adult ALL.

  2004cites this paper
• Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.

  2004cites this paper
• High-dose melphalan and autotransplantation followed by post transplant maintenance chemotherapy for acute lymphoblastic leukemia in first remission

  2004cites this paper
• Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial.

  2004cites this paper
• Rescue therapy combining intermediate-dose cytarabine with amsacrine and etoposide in relapsed adult acute lymphoblastic leukemia.

  2004cites this paper